Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

Harvard, S; Guh, D; Bansback, N; Richette, P; Saraux, A; Fautrel, B; Anis, A

Anis, A (reprint author), Ctr Hlth Evaluat & Outcome Sci, 588-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.

COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017; 15 ( ):

Abstract

Background: Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索